1. Bone marrow transplantation for therapy-related acute myeloid leukemia in congenital retinoblastoma associated with 13q deletion syndrome.
- Author
-
Hon C, Chan GC, Ha SY, Ma SK, Wong KF, and Au WY
- Subjects
- Acute Disease, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carboplatin administration & dosage, Cryosurgery, Cryotherapy, Cyclosporine administration & dosage, DNA-Binding Proteins genetics, Enzyme Inhibitors administration & dosage, Eye Neoplasms congenital, Eye Neoplasms genetics, Eye Neoplasms radiotherapy, Eye Neoplasms surgery, Female, Histone-Lysine N-Methyltransferase, Humans, Infant, Newborn, Leukemia, Myeloid chemically induced, Leukemia, Myeloid genetics, Myeloid-Lymphoid Leukemia Protein, Neoplasm Proteins antagonists & inhibitors, Neoplasm Proteins genetics, Neoplasm Recurrence, Local, Neoplasms, Multiple Primary congenital, Neoplasms, Multiple Primary genetics, Neoplasms, Multiple Primary radiotherapy, Neoplasms, Multiple Primary surgery, Neoplasms, Second Primary chemically induced, Remission Induction, Retinoblastoma congenital, Retinoblastoma genetics, Retinoblastoma radiotherapy, Retinoblastoma surgery, Teniposide administration & dosage, Topoisomerase II Inhibitors, Vincristine administration & dosage, Antineoplastic Combined Chemotherapy Protocols adverse effects, Chromosome Deletion, Chromosomes, Human, Pair 13 ultrastructure, Enzyme Inhibitors adverse effects, Eye Neoplasms drug therapy, Leukemia, Myeloid therapy, Neoplasms, Multiple Primary drug therapy, Neoplasms, Second Primary therapy, Peripheral Blood Stem Cell Transplantation, Proto-Oncogenes, Retinoblastoma drug therapy, Transcription Factors
- Abstract
Children with constitutional deletion of the long arm of chromosome 13 are at risk for retinoblastoma (RB) due to loss of the RB tumor suppressor gene. The prognosis is poor since the tumors are often bilateral, aggressive, and recurrent and the patients often harbor other congenital abnormalities. One further complication is that of therapy-related malignancies later in life. We report a case of allogeneic stem cell transplantation for therapy-related acute myeloid leukemia in an 8-year-old girl after multimodality treatment for refractory bilateral relapsing RB, with excellent outcome in both the ophthalmic and marrow disease.
- Published
- 2004
- Full Text
- View/download PDF